1. Home
  2. BGMS vs ACON Comparison

BGMS vs ACON Comparison

Compare BGMS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio Green Med Solution Inc.

BGMS

Bio Green Med Solution Inc.

N/A

Current Price

$0.94

Market Cap

6.1M

Sector

N/A

ML Signal

N/A

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$1.94

Market Cap

6.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGMS
ACON
Founded
1996
2008
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
BGMS
ACON
Price
$0.94
$1.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.3K
★ 25.7K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.82
EPS
N/A
★ N/A
Revenue
N/A
★ $75,730.00
Revenue This Year
N/A
$44.55
Revenue Next Year
$80,482.00
$123.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 65.62
52 Week Low
$0.57
$1.85
52 Week High
$2.80
$9.36

Technical Indicators

Market Signals
Indicator
BGMS
ACON
Relative Strength Index (RSI) 53.27 35.90
Support Level $0.82 N/A
Resistance Level $1.13 $3.54
Average True Range (ATR) 0.08 0.11
MACD 0.01 -0.02
Stochastic Oscillator 51.39 17.86

Price Performance

Historical Comparison
BGMS
ACON

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: